Pluristem Therapeutics Inc (PSTI)

[zzaatt]

Definitely worth re-reading this writeup!

What is really interesting is the possibility of a T.F./Pluristem partnership to supply a multitude of biotechs with the basic infrastructure and technology to manufacture MSC products. This means Pluristem playing a role in the industry that goes way beyond their own individual path to approval for specific products. This could provide Pluristem with an income stream that bypasses the binary thumbs up/down in clinical trials, and thus de-risking the funding issue.



To minimize some of these existing gaps in processes and quality, the Israeli cell therapy firm has entered into a strategic partnership with bioprocessing vendor Thermo Fisher and hopes to address the industry as a whole rather than a specific therapy.

“The main goal of this partnership is to mutually develop solutions based on the knowledge accumulated in both companies in order to provide the market with better products, which will be able to support the growth required in the industry,” Yanay said.